North America Patient Registry Software Market

Market Introduction

A patient registry is the database that collects uniform data about a population of disease or condition, and that aids a predefined clinical or scientific. Patient registry software contains databases that are maintained through collection of secondary data related to diagnosis, procedure, or condition of patient, for noting the number of new medical devices being used or going through a new procedure. The patient registry software plays a crucial role in post-marketing surveillance of pharmaceuticals.

Thus, a development of digital infrastructure in healthcare is expected to create a significant demand for patient registry software in the coming years, which is further anticipated to drive the patient registry software market.

The effectiveness of patient registry software to gather and analyze patient data is expected to have constructive impact on the adoption of patient registry software in the region. Moreover, majority of the market players, research centers, and academic institutions are focusing on the adoption of patient registries with an aim to streamline the patient data collection and analysis. In February 2021, the Leukemia & Lymphoma Society (LLS) announced strategic partnership with Ciitizen, a significant player in digital health solution in order to study on the relation between coronavirus and vaccination amongst blood cancer patients. The institution launched LLS National Patient Registry in order to gather data of blood cancer patients for the study. Further, in April 2020, the American Heart Association announced development of a novel patient registry to collect data, which will help the researchers to understand co-relation between coronavirus, cardiovascular diseases, and related treatment protocols. Moreover, in July 2020, Oracle and the National Institutes of Health (NIH) established a patient data registry to gather COVID-19 patients’ data. The partnership has termed this platform as COVID-19 Prevention Network (CoVPN). In addition, in April 2020, IQVIA Inc. announced the launch of a broad and open patient registry platform for advanced understanding and research of covid-19. These developments are likely to have constructive impact on the North America patient registry software market during and post-pandemic period.

North America Patient Registry Software Strategic Insights

Strategic insights for the North America Patient Registry Software provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Patient Registry Software Report Scope

North America Patient Registry Software Regional Insights

The geographic scope of the North America Patient Registry Software refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The North America patient registry software market is expected to grow from US$ 385.9 million in 2020 to US$ 943.2 million by 2027; it is estimated to grow at a CAGR of 13.6% from 2020 to 2027. Cloud-based or web-based electronic health records (EHRs) have been used by independent physicians since the past few years. Various organizations are establishing and developing cloud-based registries for multiple medical conditions and procedures. For instance, the Orphan Disease Center collaborated with Pulse Infoframe—a medical informatics company—to build a suite of rare disease patient registries on cloud-based technologies. In March 2018, ONKOS Surgical launched a cloud-based onco-orthology registry in collaboration with the Rush University Medical Center in Chicago, Illinois. This launch created a major milestone for the musculoskeletal oncology community of surgeons and patients. The registry provides a research platform to enable individual institutions to prospectively collect data alongside partnering with other leading institutions in the country to answer questions that would potentially impact the treatment framework in future. The emergence of similar cloud-based patient registries is expected to offer lucrative opportunities for the global patient registry software market players during the forecast period.

Key Market Segments

In terms of software, the integrated segment accounted for the largest share of the North America patient registry software market in 2019. In terms of database, the commercial segment held a larger market share of the patient registry software market in 2019. In terms of type of registry, the disease registry segment held a larger market share of the patient registry software market in 2019. In terms of mode of delivery, the cloud-based segment held a larger market share of the patient registry software market in 2019. In terms of pricing model, the subscription segment held a larger market share of the patient registry software market in 2019.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the patient registry software market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are IQVIA Inc.

,

,

,

,

,

,

,

,

,

Reasons to buy report

• To understand the North America patient registry software market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for North America patient registry software market
• Efficiently plan M&A and partnership deals in North America patient registry software market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America patient registry software market
• Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.

NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET SEGMENTATION

By Software

• Standalone
• Integrated

By Database

• Public
• Commercial

By Type of Registry

• Product Registry
• Disease Registry
  • Cardiovascular Disease Registry
  • Others
• Health Service Registry

By Mode of Delivery

• On-Premises
• Cloud-Based

By Pricing Model

• Ownership
• Subscription

By Country

• North America
  • US
  • Canada
  • Mexico

Companies Mentioned

1. IQVIA Inc.
2. FIGmd Inc.
3. Medstreaming
4. Open Text Corporation
5. Evado Clinical
6. LUMEDX
7. CEDARON
8. IBM Corporation
9. Mckesson Corporation
10. Dacima Software Inc